Abstract
The most advanced research on the use of human fetal tissue has been done in Parkinson’s disease, which affects about 1.5 million people in the USA only. Patients with Parkinson’s disease experience tremors, slurred speed, and slowness of movement that eventually progresses to total paralysis. In this progressive, debilitating illness, the cells in a small part of the brain called the substantia nigra are destroyed, depriving the striatum (the part of the brain that controls movement) of a critical molecule called dopamine. Despite devastating loss of motor control, mental faculties in Parkinson’s patients remain intact, and while the disease is in itself not fatal, patients often succumb to complications such as injuries from falls or pneumonia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Curtis MA, Faull RLM, Eriksson PS. The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci. 2007;8:712–23.
Vandenbosch R, Borgs L, Beukelaers P, Belachew S, Moonen G, Nguyen L, Malgrange B. Adult neurogenesis and the diseased brain. Curr Med Chem. 2009;16(6):652–66.
Kaneko N, Sawamoto K. Adult neurogenesis in physiological and pathological conditions. Brain Nerve. 2008;60(4):319–28.
Linnarsson S, Willson CA, Ernfors P. Cell death in regenerating populations of neurons in BDNF mutant mice. Brain Res Mol Brain Res. 2000;75(1):61–9.
Bhattacharya N. A study and follow-up (1999–2009) of human fetal neurotransplants at a heterotopic site outside the brain in patients of advanced Idiopathic Parkinsonism. In: Bhattacharya N, Stubblefield P, editors. Regenerative medicine using pregnancy-specific biological substances. London: Springer-Verlag Limited; 2011. p. 407. doi:10.1007/978-1-84882-718-9_39.
Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76.
Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson’s disease rating scale. In: Fahn S, Marden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease, vol. 2. Macmillan Healthcare Information: Florham Park; 1987. p. 153–63.
Parashos SA, Johnson ML, Erickson-Davis C, Wielinski CL. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test. J Geriatr Psychiatry Neurol. 2009;22(4):228–34.
Zigmnond-AS S-RP. The hospital anxiety and depression-scale. Acta Psychiatr Scand. 1983;67:361–70.
Snaith RP, Taylor CM. Rating scales for depression and anxiety: a current perspective. Br J Clin Pharmacol. 1985;19:17S–20.
Channer KS, James MA, Papouchado M, Res JR. Anxiety and depression in patients with chest pain referred for exercise testing. Lancet. 1985;2:820–2.
Snaith RP, Zigmond AS. The hospital anxiety and depression scale manual. Windsor: NFER-Nelson; 1994. p. 9.
Yrjö TK, Emilia K, Vasily S, Wagner HD, Jaakko L, Veli-Matti T, Zygmunt M. Extracellular matrix and tissue regeneration. In: Gustav S, editor. Regenerative medicine. Dordrecht: Springer; 2011. p. 21–80. doi:10.1007/978-90-481-9075-1_2. Part 1.
Yamazaki Y, Makino H, Hamaguchi-Hamada K, Hamada S, Sugino H, Kawase E, Miyata T, Ogawa M, Yanagimachi R, Yagi T. Assessment of the developmental totipotency of neural cells in the cerebral cortex of mouse embryo by nuclear transfer. Proc Natl Acad Sci USA. 2001;98(24):14022–6.
Rinkevich B. Human natural chimerism: an acquired character or a vestige of evolution? Hum Immunol. 2001;62(6):651–7.
Samanta BK. A study of fetal neuronal tissue graft at a heterotopic transplantation site and its implications. PhD thesis (Jadavpur University, Kolkata). 2009.
Dunnett SB, Björklund A. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature. 1999;399(6738 Suppl):A32–9.
Acknowledgment
1.Investigator 1 is grateful to the Department of Science and Technology, Government of West Bengal, who supported the Sr. investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006. The work started at Bijoygarh Government Hospital (1999–2006), Calcutta, India, and was followed up at Vidyasagore Government Hospital subsequently. The author gratefully acknowledges the support of the patients who volunteered for this research work. The guidance of Prof. K. L. Mukherjee of Biochemistry and Prof. M. K. Chhetri, former Director of Health Services, is gratefully acknowledged.
2.Investigator 2 was associated from the concept state to its implementation phase including follow-up as technical guide and also actual periodic participation during his visit to Calcutta, India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Bhattacharya, N., Chaudhuri, A. (2013). A Study and Follow-Up (1999–2012) of Fetal Midbrain Tissue Transplant (Iatrogenic Chimera) at a Heterotopic Site in Axilla as a Treatment Support in Cases of Adult Idiopathic Parkinsonism Patients. In: Bhattacharya, N., Stubblefield, P. (eds) Human Fetal Tissue Transplantation. Springer, London. https://doi.org/10.1007/978-1-4471-4171-6_30
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4171-6_30
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4170-9
Online ISBN: 978-1-4471-4171-6
eBook Packages: MedicineMedicine (R0)